|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 97.69 USD | -1.80% |
|
+6.75% | +46.70% |
| May. 19 | Cimpress Prices $1.1 Billion Term Loan B Due 2033 | MT |
| May. 19 | Cimpress plc Announces Pricing and Allocation of $1,100 Million Term Loan B Maturing in 2033 | CI |
| Fiscal Period: June | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.23 | 1.78 | 3.31 | 8.27 | 7.51 | |||||
Return on Total Capital | 6.04 | 2.63 | 5.16 | 13.11 | 12.34 | |||||
Return On Equity % | 20.91 | 13.64 | 38.56 | -31.85 | -2.38 | |||||
Return on Common Equity | 18.14 | 11.51 | 33.27 | -29.61 | -2.64 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 48.8 | 48.3 | 46.73 | 48.51 | 47.53 | |||||
SG&A Margin | 31.74 | 34.14 | 31.93 | 30.24 | 30.34 | |||||
EBITDA Margin % | 10.07 | 6.33 | 6.88 | 10.24 | 9.11 | |||||
EBITA Margin % | 7.3 | 4.03 | 4.99 | 8.48 | 7.37 | |||||
EBIT Margin % | 5.22 | 2.14 | 3.46 | 7.53 | 6.81 | |||||
Income From Continuing Operations Margin % | -2.89 | -1.75 | -6.03 | 5.4 | 0.38 | |||||
Net Income Margin % | -3 | -1.88 | -6.04 | 5.28 | 0.44 | |||||
Net Avail. For Common Margin % | -3 | -1.88 | -6.04 | 5.28 | 0.44 | |||||
Normalized Net Income Margin | -0.01 | 0.39 | 0.24 | 2.33 | 1.95 | |||||
Levered Free Cash Flow Margin | 10.94 | 2.04 | 2.29 | 6.92 | 5.75 | |||||
Unlevered Free Cash Flow Margin | 13.73 | 4.05 | 4.58 | 9.2 | 7.87 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.3 | 1.33 | 1.53 | 1.76 | 1.76 | |||||
Fixed Assets Turnover | 5.69 | 7.37 | 8.42 | 9.3 | 9.32 | |||||
Receivables Turnover (Average Receivables) | 60.8 | 50.41 | 46.93 | 49.9 | 51.23 | |||||
Inventory Turnover (Average Inventory) | 17.67 | 15.17 | 13.99 | 16.55 | 17.02 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.83 | 0.9 | 0.68 | 0.69 | 0.66 | |||||
Quick Ratio | 0.6 | 0.56 | 0.37 | 0.41 | 0.4 | |||||
Operating Cash Flow to Current Liabilities | 0.42 | 0.32 | 0.2 | 0.53 | 0.39 | |||||
Days Sales Outstanding (Average Receivables) | 6 | 7.24 | 7.78 | 7.33 | 7.13 | |||||
Days Outstanding Inventory (Average Inventory) | 20.65 | 24.06 | 26.09 | 22.12 | 21.45 | |||||
Average Days Payable Outstanding | 50.39 | 60.49 | 67.46 | 66.54 | 66.74 | |||||
Cash Conversion Cycle (Average Days) | -23.74 | -29.19 | -33.59 | -37.09 | -38.16 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | -498.62 | -493.21 | -292.93 | -333.17 | -302.98 | |||||
Total Debt / Total Capital | 125.09 | 125.43 | 151.83 | 142.89 | 149.27 | |||||
LT Debt/Equity | -480.44 | -480.89 | -285.73 | -325.35 | -295.84 | |||||
Long-Term Debt / Total Capital | 120.53 | 122.3 | 148.1 | 139.53 | 145.74 | |||||
Total Liabilities / Total Assets | 117.33 | 116.77 | 132.34 | 127.32 | 128.63 | |||||
EBIT / Interest Expense | 1.17 | 0.66 | 0.95 | 2.07 | 2.01 | |||||
EBITDA / Interest Expense | 2.62 | 2.33 | 2.2 | 3.07 | 2.96 | |||||
(EBITDA - Capex) / Interest Expense | 2.29 | 1.75 | 1.72 | 2.61 | 2.19 | |||||
Total Debt / EBITDA | 6.22 | 8.25 | 7.08 | 4.69 | 5.01 | |||||
Net Debt / EBITDA | 4.95 | 6.75 | 6.38 | 4.12 | 4.32 | |||||
Total Debt / (EBITDA - Capex) | 7.12 | 10.98 | 9.03 | 5.51 | 6.77 | |||||
Net Debt / (EBITDA - Capex) | 5.67 | 8.98 | 8.14 | 4.84 | 5.85 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 4.48 | 12.1 | 6.65 | 6.89 | 3.38 | |||||
Gross Profit, 1 Yr. Growth % | 3.63 | 9.31 | 3.17 | 10.97 | 1.29 | |||||
EBITDA, 1 Yr. Growth % | -8.73 | -32.75 | 15.97 | 58.92 | -7.95 | |||||
EBITA, 1 Yr. Growth % | -10.17 | -41.87 | 32.03 | 81.87 | -10.16 | |||||
EBIT, 1 Yr. Growth % | -14.76 | -57.74 | 72.65 | 132.27 | -6.45 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -189.22 | -38.67 | 267.24 | -195.74 | -92.77 | |||||
Net Income, 1 Yr. Growth % | -193.22 | -36.25 | 242.31 | -193.39 | -91.39 | |||||
Normalized Net Income, 1 Yr. Growth % | -100.31 | 481.85 | -32.83 | 927.94 | -13.49 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -199.67 | -36.52 | 240.25 | -190.77 | -90.98 | |||||
Accounts Receivable, 1 Yr. Growth % | 46.49 | 26.06 | 5.43 | -4.12 | 5.75 | |||||
Inventory, 1 Yr. Growth % | -12.64 | 80.93 | -14.91 | -10.03 | 16.34 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -15.88 | -11.72 | -0.86 | -5.62 | 12.38 | |||||
Total Assets, 1 Yr. Growth % | 20.25 | -0.68 | -14.43 | 2.01 | 4.02 | |||||
Tangible Book Value, 1 Yr. Growth % | 10.74 | 3.86 | 6.8 | -6.41 | 4.43 | |||||
Common Equity, 1 Yr. Growth % | 10.28 | 10.14 | 25.91 | -11.71 | 6.06 | |||||
Cash From Operations, 1 Yr. Growth % | -21.64 | -17.23 | -40.65 | 169.19 | -15.01 | |||||
Capital Expenditures, 1 Yr. Growth % | -23.66 | 40.28 | -0.5 | 2.15 | 62.08 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 72.47 | -79.74 | 20.12 | 222.59 | -14.15 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 67.91 | -67.75 | 20.65 | 114.54 | -11.6 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -2.92 | 7.87 | 9.34 | 6.77 | 5.12 | |||||
Gross Profit, 2 Yr. CAGR % | -3.18 | 6.38 | 6.19 | 7 | 6.02 | |||||
EBITDA, 2 Yr. CAGR % | -9.96 | -21.61 | -11.69 | 35.76 | 20.95 | |||||
EBITA, 2 Yr. CAGR % | -10.56 | -27.65 | -12.39 | 54.96 | 27.83 | |||||
EBIT, 2 Yr. CAGR % | -14.05 | -39.78 | -14.59 | 100.25 | 47.41 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -10.46 | -22.41 | 50.08 | 87.51 | -73.69 | |||||
Net Income, 2 Yr. CAGR % | -9.58 | -19.27 | 47.72 | 78.79 | -71.65 | |||||
Normalized Net Income, 2 Yr. CAGR % | -95.35 | -60.89 | 97.7 | 162.77 | 198.2 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -0.17 | -16.69 | 47 | 75.74 | -71.39 | |||||
Accounts Receivable, 2 Yr. CAGR % | -8.59 | 35.89 | 15.28 | 0.54 | 0.69 | |||||
Inventory, 2 Yr. CAGR % | 2.78 | 25.72 | 24.08 | -12.5 | 2.31 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -7.9 | -13.83 | -6.45 | -3.27 | 2.99 | |||||
Total Assets, 2 Yr. CAGR % | 8.08 | 9.28 | -7.81 | -6.57 | 3.01 | |||||
Tangible Book Value, 2 Yr. CAGR % | 25.6 | 7.24 | 5.32 | -0.02 | -1.14 | |||||
Common Equity, 2 Yr. CAGR % | 84.64 | 10.21 | 17.76 | 5.43 | -3.23 | |||||
Cash From Operations, 2 Yr. CAGR % | -10.5 | -19.46 | -29.91 | 26.39 | 51.25 | |||||
Capital Expenditures, 2 Yr. CAGR % | -26.11 | 3.48 | 18.14 | 0.82 | 28.67 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 33.68 | -41.45 | -50.67 | 96.85 | 66.42 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 33.88 | -26.95 | -37.62 | 60.89 | 37.72 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -0 | 1.63 | 7.47 | 8.52 | 5.63 | |||||
Gross Profit, 3 Yr. CAGR % | -1.22 | 1.1 | 5.3 | 7.76 | 5.06 | |||||
EBITDA, 3 Yr. CAGR % | -0.28 | -17.18 | -10.68 | 7.42 | 19.27 | |||||
EBITA, 3 Yr. CAGR % | 2.55 | -21.06 | -11.59 | 11.76 | 29.21 | |||||
EBIT, 3 Yr. CAGR % | 2.54 | -30.39 | -14.45 | 19.22 | 55.38 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 17 | -18.52 | 30.28 | 29.19 | -36.66 | |||||
Net Income, 3 Yr. CAGR % | 21.12 | -17.01 | 30.66 | 26.78 | -34.95 | |||||
Normalized Net Income, 3 Yr. CAGR % | -80.94 | -50.74 | -53.16 | 242.5 | 81.44 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 30.03 | -11.46 | 33.16 | 25.17 | -34.69 | |||||
Accounts Receivable, 3 Yr. CAGR % | -3.05 | 1.75 | 24.87 | 8.41 | 2.25 | |||||
Inventory, 3 Yr. CAGR % | 4.94 | 24.1 | 10.38 | 11.47 | -3.79 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -4.88 | -9.19 | -9.71 | -6.17 | 1.69 | |||||
Total Assets, 3 Yr. CAGR % | 9.72 | 5.08 | 0.73 | -4.65 | -3.17 | |||||
Tangible Book Value, 3 Yr. CAGR % | 26.68 | 17.89 | 7.1 | 1.25 | 1.44 | |||||
Common Equity, 3 Yr. CAGR % | 68.66 | 55.43 | 15.21 | 6.98 | 5.64 | |||||
Cash From Operations, 3 Yr. CAGR % | 11.31 | -12.8 | -27.25 | 9.76 | 10.73 | |||||
Capital Expenditures, 3 Yr. CAGR % | -14.17 | -8.51 | 2.14 | 12.55 | 18.1 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 14.25 | -28.16 | -25.61 | -7.75 | 49.28 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 16.85 | -16.17 | -13.65 | -5.84 | 31.78 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 7.71 | 6.22 | 3.5 | 3.65 | 6.52 | |||||
Gross Profit, 5 Yr. CAGR % | 4.29 | 4.87 | 1.85 | 3.42 | 5.59 | |||||
EBITDA, 5 Yr. CAGR % | 1.59 | 1.64 | -4.23 | 0.92 | 0.83 | |||||
EBITA, 5 Yr. CAGR % | 2.87 | 7.53 | -2.63 | 3.38 | 2.46 | |||||
EBIT, 5 Yr. CAGR % | 1.82 | 12.21 | -3.2 | 6.23 | 6.35 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 8.25 | -6.87 | 31.75 | 13.72 | -31.3 | |||||
Net Income, 5 Yr. CAGR % | 7.41 | -5.4 | 33.58 | 12.81 | -29.08 | |||||
Normalized Net Income, 5 Yr. CAGR % | -69.08 | 117.93 | -23.79 | -3.77 | -1.79 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 12.76 | -1.9 | 39.11 | 16.47 | -28.01 | |||||
Accounts Receivable, 5 Yr. CAGR % | 9.41 | 5.61 | 3.9 | 1.26 | 14.57 | |||||
Inventory, 5 Yr. CAGR % | 31.04 | 22.17 | 12.22 | 7.91 | 7.08 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | -3.33 | -6.41 | -5.51 | -6.87 | -4.83 | |||||
Total Assets, 5 Yr. CAGR % | 8.32 | 5.23 | 2.34 | 0.25 | 1.63 | |||||
Tangible Book Value, 5 Yr. CAGR % | 21.3 | 14.54 | 17.66 | 10.37 | 3.72 | |||||
Common Equity, 5 Yr. CAGR % | 22.08 | 45.85 | 46.08 | 33.08 | 7.44 | |||||
Cash From Operations, 5 Yr. CAGR % | 1.4 | 6.97 | -7.49 | 1.16 | -2.51 | |||||
Capital Expenditures, 5 Yr. CAGR % | -13.69 | -6.13 | -2.47 | -4.89 | 12.02 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 18.97 | -7.69 | -17.96 | 7.52 | 2.66 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 20.03 | 0.33 | -8.75 | 8.81 | 4.08 |
- Stock Market
- Equities
- CMPR Stock
- Financials Cimpress plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















